Recently, TMBJ members Dr. Liu Jin, Dr. Yu Yuanyuan, Ms. Wu Xiaoqiu, Mr. Li Dijie, and Ms. Wang Luyao attended the 2019 ASBMR annual meeting held in Orlando, USA. At the meeting, Dr. Liu Jin was invited to give plenary oral presentation on ‘Unraveling the mystery behind bone-cartilage crosstalk: Osteoclast derived exosomal microRNAs deprive the resistance of cartilage to matrix degeneration, angiogenesis and innervation in osteoarthritis’, and received 2019 ASBMR Young Investigator Award for his excellent performance in research. Dr. Yu Yuanyuan made poster presentation on ‘A Potential Next Generation Sclerostin Inhibitor Specifically Targets Sclerostin Monomer for Bone Anabolic Therapy with Low Cardiovascular Risk to Reverse Established Osteoporosis in Ovariectomized Rats’. Ms. Wu Xiaoqiu made poster presentation on ‘PARP1 interacts with ezrin contributing to metastasis in osteosarcoma’. Mr. Li Dijie made poster presentation on ‘Targeting a newly identified lncRNA and its interaction with HuR to promote osteogenic cells migration to bone formation surface for reversing established age-related osteoporosis’. Ms. Wang Luyao gave plenary oral presentation on ‘A potential next generation sclerostin inhibitor specifically targets sclerostin Loop3 for bone anabolic therapy with low cardiovascular risk in osteogenesis imperfecta mice’.

Dr. Liu Jin received 2019 ASBMR Young Investigator Award

Mr. Li Dijie presented their work                                               

                                                                          Ms. Wu Xiaoqiu presented their work

Ms. Wang Luyao presented their work

TMBJ members in 2019 ASBMR annual meeting